PHILADELPHIA, May 4, 2020: Morgan Lewis represented Formula Pharmaceuticals Inc. in its merger with CoImmune Inc.
Formula is a privately held biopharmaceutical company developing a proprietary, next-generation chimeric antigen receptor (CAR) immunotherapy platform. CoImmune specializes in the development of personalized immuno-oncology therapies
Partners Jeff Bodle and Joanne Soslow and associate Conor Larkin represented Formula.